Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial
- Mette S. van Ramshorst
- , Anna van der Voort
- , Dutch Breast Cancer Research Group (BOOG)
- , Erik D. van Werkhoven
- , Ingrid A. Mandjes
- , Inge Kemper
- , Vincent O. Dezentjé
- , Irma M. Oving
- , Aafke H. Honkoop
- , Lidwine W. Tick
- , Agnes J. van de Wouw
- , Caroline M. Mandigers
- , Laurence J. van Warmerdam
- , Jelle Wesseling
- , Marie Jeanne T. Vrancken Peeters
- , Sabine C. Linn
- , Gabe S. Sonke*
*Corresponding author for this work
- Netherlands Cancer Institute
- Reinier de Graaf Groep
- Ziekenhuisgroep Twente
- Department of Medical Oncology
- Maxima Medical Centre
- VieCuri Medisch Centrum
- Canisius Wilhelmina Hospital
- Catharina Cancer Institute
- Utrecht University
Research output: Contribution to journal › Article › Academic › peer-review
430
Citations
(Scopus)
356
Downloads
(Pure)